Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Prepaid Assets: 2020-2024

Historic Prepaid Assets for Mereo BioPharma Group (MREO) over the last 5 years, with Dec 2024 value amounting to $2.2 million.

  • Mereo BioPharma Group's Prepaid Assets fell 29.66% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 29.66%. This contributed to the annual value of $2.2 million for FY2024, which is 57.82% down from last year.
  • Latest data reveals that Mereo BioPharma Group reported Prepaid Assets of $2.2 million as of FY2024, which was down 57.82% from $5.2 million recorded in FY2023.
  • In the past 5 years, Mereo BioPharma Group's Prepaid Assets ranged from a high of $5.4 million in FY2022 and a low of $2.1 million during FY2020.
  • Its 3-year average for Prepaid Assets is $4.3 million, with a median of $5.2 million in 2023.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 81.48% in 2021, then plummeted by 57.82% in 2024.
  • Over the past 5 years, Mereo BioPharma Group's Prepaid Assets (Yearly) stood at $2.1 million in 2020, then surged by 81.48% to $3.8 million in 2021, then soared by 44.34% to $5.4 million in 2022, then dropped by 5.33% to $5.2 million in 2023, then slumped by 57.82% to $2.2 million in 2024.